Hoshino I - Search Results

1

CHAP31 induces apoptosis only via the intrinsic pathway in human esophageal cancer cells.

Murakami K, Matsubara H, Hoshino I, Akutsu Y, Miyazawa Y, Matsushita K, Sakata H, Nishimori T, Usui A, Kano M, Nishino N, Yoshida M. Murakami K, et al. Among authors: hoshino i. Oncology. 2010;78(1):62-74. doi: 10.1159/000292362. Epub 2010 Mar 6. Oncology. 2010. PMID: 20215787

2

Histone deacetylase inhibitor FK228 activates tumor suppressor Prdx1 with apoptosis induction in esophageal cancer cells.

Hoshino I, Matsubara H, Hanari N, Mori M, Nishimori T, Yoneyama Y, Akutsu Y, Sakata H, Matsushita K, Seki N, Ochiai T. Hoshino I, et al. Clin Cancer Res. 2005 Nov 1;11(21):7945-52. doi: 10.1158/1078-0432.CCR-05-0840. Clin Cancer Res. 2005. PMID: 16278420

3

Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice.

Akutsu Y, Matsubara H, Urashima T, Komatsu A, Sakata H, Nishimori T, Yoneyama Y, Hoshino I, Murakami K, Usui A, Kano M, Ochiai T. Akutsu Y, et al. Among authors: hoshino i. Int J Oncol. 2007 Sep;31(3):509-15. Int J Oncol. 2007. PMID: 17671676

4

Gene expression profiling induced by histone deacetylase inhibitor, FK228, in human esophageal squamous cancer cells.

Hoshino I, Matsubara H, Akutsu Y, Nishimori T, Yoneyama Y, Murakami K, Komatsu A, Sakata H, Matsushita K, Ochiai T. Hoshino I, et al. Oncol Rep. 2007 Sep;18(3):585-92. Oncol Rep. 2007. PMID: 17671705

5

Combinatory gene therapy with electrotransfer of midkine promoter-HSV-TK and interleukin-21.

Hanari N, Matsubara H, Hoshino I, Akutsu Y, Nishimori T, Murakami K, Sakata H, Miyazawa Y, Ochiai T. Hanari N, et al. Among authors: hoshino i. Anticancer Res. 2007 Jul-Aug;27(4B):2305-10. Anticancer Res. 2007. PMID: 17695518 Free article.

6

Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients.

Hoshino I, Matsubara H, Akutsu Y, Nishimori T, Yoneyama Y, Murakami K, Sakata H, Matsushita K, Ochiai T. Hoshino I, et al. Oncol Rep. 2007 Oct;18(4):867-71. Oncol Rep. 2007. PMID: 17786348

7

Role of histone deacetylase inhibitor in adenovirus-mediated p53 gene therapy in esophageal cancer.

Hoshino I, Matsubara H, Akutsu Y, Nishimori T, Yoneyama Y, Murakami K, Sakata H, Matsushita K, Komatsu A, Brooks R, Ochiai T. Hoshino I, et al. Anticancer Res. 2008 Mar-Apr;28(2A):665-71. Anticancer Res. 2008. PMID: 18507005 Free article.

8

Combined effects of p53 gene therapy and leptomycin B in human esophageal squamous cell carcinoma.

Hoshino I, Matsubara H, Komatsu A, Akutsu Y, Nishimori T, Yoneyama Y, Murakami K, Sakata H, Matsushita K, Miyazawa Y, Brooks R, Yoshida M, Ochiai T. Hoshino I, et al. Oncology. 2008;75(1-2):113-9. doi: 10.1159/000155212. Epub 2008 Sep 11. Oncology. 2008. PMID: 18784437

9

Clinical and pathologic evaluation of the effectiveness of neoadjuvant chemoradiation therapy in advanced esophageal cancer patients.

Akutsu Y, Matsubara H, Shuto K, Uesato M, Mori M, Hoshino I, Shiratori T, Miyazawa Y, Ito H, Uno T. Akutsu Y, et al. Among authors: hoshino i. World J Surg. 2009 May;33(5):1002-9. doi: 10.1007/s00268-008-9899-8. World J Surg. 2009. PMID: 19247705

10

[The problems of surgery in aged esophageal cancer].

Akutsu Y, Shuto K, Uesato M, Hoshino I, Matsubara H. Akutsu Y, et al. Among authors: hoshino i. Nihon Ronen Igakkai Zasshi. 2009 Jul;46(4):313-6. doi: 10.3143/geriatrics.46.313. Nihon Ronen Igakkai Zasshi. 2009. PMID: 19713659 Free article. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters